The store will not work correctly when cookies are disabled.
1-(6-(5-chloro-2-fluorophenyl)-1H-pyrrolo[2,3-b]pyridin-4-yl)-3-methyl-1H-imidazo[4,5-c]pyridin-2(3H)-one
ID: ALA4474551
PubChem CID: 155537238
Max Phase: Preclinical
Molecular Formula: C20H13ClFN5O
Molecular Weight: 393.81
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: Cn1c(=O)n(-c2cc(-c3cc(Cl)ccc3F)nc3[nH]ccc23)c2ccncc21
Standard InChI: InChI=1S/C20H13ClFN5O/c1-26-18-10-23-6-5-16(18)27(20(26)28)17-9-15(25-19-12(17)4-7-24-19)13-8-11(21)2-3-14(13)22/h2-10H,1H3,(H,24,25)
Standard InChI Key: HESAPDRVFTXZTE-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 32 0 0 0 0 0 0 0 0999 V2000
22.2237 -4.5894 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2226 -5.4090 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9306 -5.8179 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.9288 -4.1806 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6374 -4.5858 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6377 -5.4090 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.4207 -5.6632 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.9044 -4.9970 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.4203 -4.3313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9264 -3.3634 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.5164 -5.8173 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8088 -5.4064 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1012 -5.8138 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1001 -6.6318 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8125 -7.0408 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5171 -6.6311 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2256 -7.0383 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
23.5829 -2.8838 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.3280 -2.1074 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.2607 -2.8878 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.5145 -2.1095 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9679 -1.5025 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1674 -1.6727 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.9164 -2.4552 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4647 -3.0588 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3608 -3.1342 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.8065 -1.4449 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3940 -5.4043 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
4 10 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
2 11 1 0
16 17 1 0
10 18 1 0
18 19 1 0
19 21 1 0
20 10 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 20 1 0
18 26 2 0
19 27 1 0
13 28 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 393.81 | Molecular Weight (Monoisotopic): 393.0793 | AlogP: 4.06 | #Rotatable Bonds: 2 |
Polar Surface Area: 68.50 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 3.48 | CX LogP: 3.70 | CX LogD: 3.70 |
Aromatic Rings: 5 | Heavy Atoms: 28 | QED Weighted: 0.49 | Np Likeness Score: -1.25 |
References
1. Wang H, Lawson JD, Scorah N, Kamran R, Hixon MS, Atienza J, Dougan DR, Sabat M.. (2016) Design, synthesis and optimization of novel Alk5 (activin-like kinase 5) inhibitors., 26 (17): [PMID:27460209] [10.1016/j.bmcl.2016.07.030] |